Nov. 8 at 8:35 AM
$TECX Tectonic Therapeutics posts strong Phase 1b results in PH-HFrEF and reports
$268.4M in cash, giving a solid runway through 2028. https://biotechhealthx.com/biotech-news/tectonic-therapeutics-tecx-surges-on-positive-tx45-trial-data/